| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | $14.8B | $11.0B | $2.6B | $3.5B | $3.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B | $0.3B | $0.4B | $0.4B |
| Operating Income | $0.8B | $0.7B | $0.9B | $0.6B | $0.2B | $-0.3B | $0.9B | $0.8B |
| Net Income | $0.3B | $0.3B | $0.7B | $0.2B | $-0.1B | $-0.1B | $0.1B | $0.2B |
| EPS (Basic) | $1.24 | $1.00 | $2.59 | — | — | $-0.59 | $0.35 | $0.71 |
| EPS (Diluted) | $1.22 | $0.99 | $2.57 | — | — | $-0.59 | $0.34 | $0.69 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.3B | $12.7B | $16.9B | $15.1B | $14.4B | $15.7B | $13.7B | $13.7B |
| Current Assets | $3.5B | $3.4B | $5.2B | $3.3B | $2.9B | $4.7B | $2.7B | $2.9B |
| Cash & Equivalents | $0.6B | $0.7B | $2.0B | $0.3B | $0.5B | $2.5B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.5B | $4.2B | $5.0B | $3.3B | $2.9B | $2.3B | $2.7B | $2.5B |
| Stockholders' Equity | $3.1B | $3.0B | $3.7B | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | $0.8B | $0.7B | $0.7B | $0.2B | $1.0B | $1.0B |
| Investing Cash Flow | — | — | $0.2B | $-0.8B | $-0.6B | $-0.4B | $-0.2B | $-2.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | $0.7B | $-0.0B | $-2.0B | $2.4B | $-0.7B | $1.8B |